NCT03502785 2025-07-10INO-5401 + INO-9012 in Combination With Atezolizumab in Locally Advanced Unresectable or Metastatic/Recurrent Urothelial CarcinomaInovio PharmaceuticalsPhase 1/2 Completed35 enrolled